Image de couverture de livre

Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Peng Zhang, Xinxin Zhang, Jinyi Lang, Shaoxiong Wu, Yan Sun, Peiguo Wang, Sufang Qiu, Xiaodong Huang, Guoxin Ren, Kun Liu, Xiaojing Du, Shaowen Xiao, Zhongqiu Wang, Youliang Weng, Ye Zhang, Hang Zhou, Wenyong Tu, Chenping Zhang, Junlin Yi
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	MedComm
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A novel allosteric driver mutation of β‐glucuronidase promotes head and neck squamous cell carcinoma progression through STT3B‐mediated PD‐L1 N‐glycosylation
par: Zhonglong Liu, et autres
Publié: (2025)

Single‐Cell and Spatial Multiomics: Applications for Diseases
par: Wentao Li, et autres
Publié: (2025)

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
par: Leilei Wu, et autres
Publié: (2024)

Fc‐null anti‐CTLA‐4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis‐inducing mishap
par: Jingjing Chen, et autres
Publié: (2024)

Separase Inhibition Enhances Gefitinib Sensitivity of Lung Cancer via PTBP1/TAK1/RIPK1‐Mediated PANoptosis
par: Zhouyangfan Peng, et autres
Publié: (2025)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
par: TingDan Hu, et autres
Publié: (2024)

CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
par: Zitong Zhao, et autres
Publié: (2024)

Phase 1b trial of anti‐HER2 antibody inetetamab and pan‐HER inhibitor pyrotinib in HER2‐positive advanced lung cancer
par: Yihua Huang, et autres
Publié: (2024)

Hypoxia‐activated ADCC‐enhanced humanized anti‐CD147 antibody for liver cancer imaging and targeted therapy with improved selectivity
par: Fang‐Zheng Qi, et autres
Publié: (2024)

N6‐methyladenosine reader YTHDF3‐mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail
par: Xinxin Li, et autres
Publié: (2024)

Structure‐based design of antibodies targeting the EBNA1 DNA‐binding domain to block Epstein–Barr virus latent infection and tumor growth
par: Yongyue Han, et autres
Publié: (2024)

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
par: Hao Wang, et autres
Publié: (2024)

Bending and Scission: When the Membraneless Condensates Meet Endosome Membrane
par: Zhengkun Zhang, et autres
Publié: (2025)

Metabolic and Epigenetic Control of CD8+ T Cell Exhaustion: The Acetate‐to‐Citrate Switch
par: Xiaoyi Lei, et autres
Publié: (2025)

Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid‐derived suppressor cells by instigating apolarity during ageing
par: Ming Wang, et autres
Publié: (2024)

Subsequent Survival and Loss of Lifetime for Patients With Progression‐Free 24 Months After Treatment in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population‐Based Analysis
par: Yang Liu, et autres
Publié: (2025)

Radiogenomics: bridging the gap between imaging and genomics for precision oncology
par: Wenle He, et autres
Publié: (2024)

Structural insight into interleukin‐4Rα and interleukin‐5 inhibition by nanobodies from a bispecific antibody
par: Weicheng Qiu, et autres
Publié: (2024)

A New Mathematical Model to Index Body Weight in Healthy Chinese Han Adults
par: Qing Zhang, et autres
Publié: (2026)

Short‐Term, Cycle‐Synchronized Adjunctive Therapy With Crocus Total Glucosides Tablets for Cardiac Protection Against Cancer Therapy‐Related Cardiac Dysfunction in Breast Cancer Patients: A Randomized, Double‐Blind, Placebo‐Controlled Trial
par: Xiaoling Liu, et autres
Publié: (2026)

State‐of‐the‐Art Strategies for Circular RNA in Cancers: Opportunity and Challenge
par: Zehao Ding, et autres
Publié: (2026)

Congenital heart disease: types, pathophysiology, diagnosis, and treatment options
par: Xiao Meng, et autres
Publié: (2024)

Inducible T Cell Costimulator Ligand and Inducible T Cell Costimulator Stratification Identify Dichotomous Tumor Microenvironment and Guide Chemo‐Immunotherapy in Small Cell Lung Cancer
par: Qiji Guo, et autres
Publié: (2026)

Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
par: Yuqing Zhao, et autres
Publié: (2024)

Avelumab mediates antibody‐dependent cellular cytotoxicity against monocyte‐derived dendritic cells through natural killer cells
par: Tatjana Sauerer, et autres
Publié: (2025)

Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer
par: Sikan Jin, et autres
Publié: (2026)

The Incremental Prognostic Value of Hyperemic Coronary Flow Velocity in Patients with Angina and Nonobstructive Coronary Artery Disease
par: Quande Liu, et autres
Publié: (2026)

Liquid–liquid phase separation in diseases
par: Xinyue Zhang, et autres
Publié: (2024)

Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival
par: Libo Zhang, et autres
Publié: (2025)

Epigenetic Regulation in Cardiovascular Diseases: Mechanisms and Therapeutic Targets
par: Wangzheqi Zhang, et autres
Publié: (2026)

Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
par: Yan Zhang, et autres
Publié: (2024)

Long‐Term High‐Fat Diet Affected Bone Marrow Microenvironment During Aging at Single‐Cell Resolution
par: Yidan Pang, et autres
Publié: (2025)

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8‐Positive T‐Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study
par: Guochao Zhang, et autres
Publié: (2026)

Advancing Design Strategy of PROTACs for Cancer Therapy
par: Hang Luo, et autres
Publié: (2025)

5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
par: Jianhua Xia, et autres
Publié: (2024)

Mechanical Signaling: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets
par: Yicen Long, et autres
Publié: (2025)

Genome‐Wide 5‐Methylcytosine and 5‐Hydroxymethylcytosine Signatures Analysis of Plasma Cell‐Free DNA in Schizophrenia
par: Gang Xue, et autres
Publié: (2025)

Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1
par: Zijun Zhang, et autres
Publié: (2025)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
par: Xiaoting Luo, et autres
Publié: (2024)

Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers
par: Jiawen Bu, et autres
Publié: (2025)